Get startedLog in
    Picture of Merck KGaA logo

    MRK — Merck KGaA Cashflow Statement

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareBalancedLarge CapFalling Star
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Merck KGaA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line3,0653,3392,8342,7862,615
    Depreciation
    Non-Cash Items62-27-3438-44
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-273-1,083-896-372-937
    Change in Accounts Receivable
    Change in Inventories
    Change in Payable / Accrued Expenses
    Change in Other Liabilities
    Net Change in Other Assets & Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities4,6164,2593,7844,5863,932
    Capital Expenditures-1,421-1,806-2,023-2,184-1,958
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-157-937131-866-2,303
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Sale of Intangible Assets
    Other Investing Cash Flow
    Cash from Investing Activities-1,578-2,743-1,892-3,050-4,261
    Financing Cash Flow Items-576-728-880-754-765
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-2,504-1,555-1,732-985628
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash543-46129535222